These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10879267)

  • 1. An enzyme immunoassay for advanced glycosylation end-products in serum.
    Nazaimoon W; Bak K
    Malays J Pathol; 1998 Dec; 20(2):83-9. PubMed ID: 10879267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum AGE-elastin derived peptides among diabetic children.
    Nicoloff G; Nikolov A; Dekov D
    Vascul Pharmacol; 2005 Oct; 43(4):193-7. PubMed ID: 16243587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
    Booth AA; Khalifah RG; Hudson BG
    Biochem Biophys Res Commun; 1996 Mar; 220(1):113-9. PubMed ID: 8602828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Products of advanced glycation in patients with type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Pokupec R; Turk N; Stavljenić-Rukavina A
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):552-9. PubMed ID: 14503994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta.
    Kim YS; Kim BC; Song CY; Hong HK; Moon KC; Lee HS
    J Lab Clin Med; 2001 Jul; 138(1):59-68. PubMed ID: 11433229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy.
    Zhou H; Tan KC; Shiu SW; Wong Y
    Nephrol Dial Transplant; 2008 Mar; 23(3):927-33. PubMed ID: 18065800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y; Lin S; Zhou J
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of serum of patients with Alzheimer's disease for the level of advanced glycation end products.
    Leszek J; Malyszczak K; Bartys A; Staniszewska M; Gamian A
    Am J Alzheimers Dis Other Demen; 2006; 21(5):360-5. PubMed ID: 17062556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
    Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
    Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress.
    Gupta A; Tripathi AK; Tripathi RL; Madhu SV; Banerjee BD
    Indian J Biochem Biophys; 2007 Oct; 44(5):373-8. PubMed ID: 18341213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products.
    Zheng F; He C; Cai W; Hattori M; Steffes M; Vlassara H
    Diabetes Metab Res Rev; 2002; 18(3):224-37. PubMed ID: 12112941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada disease.
    Kitamura M; Kitaichi N; Takeuchi M; Kitamei H; Namba K; Yamagishi SI; Iwabuchi K; Onoé K; Ohno S
    Br J Ophthalmol; 2005 Nov; 89(11):1407-9. PubMed ID: 16234440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly sensitive enzyme immunoassay for evaluation of 2'-deoxycytidine plasma level as a prognostic marker for breast cancer chemotherapy.
    Darwish IA; Mahmoud AM; Aboul-Fadl T; Al-Majed AR; Khalil NY
    Anal Chim Acta; 2009 Jan; 632(2):266-71. PubMed ID: 19110103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical detection of 3-deoxyglucosone in serum.
    Uchida Y; Kurano Y; Endo T; Aoyama M; Ito S
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1090-8. PubMed ID: 15541400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes.
    Chen BH; Jiang DY; Tang LS
    Life Sci; 2006 Aug; 79(11):1040-8. PubMed ID: 16674981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal.
    Kiho T; Kato M; Usui S; Hirano K
    Clin Chim Acta; 2005 Aug; 358(1-2):139-45. PubMed ID: 15946656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions.
    Kowluru RA
    Life Sci; 2005 Jan; 76(9):1051-60. PubMed ID: 15607333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end-products prepared in solution under high pressure contain epitopes distinct from those formed in the dry reaction at high temperature.
    Staniszewska M; Jarosz J; Jon M; Gamian A
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):71-8. PubMed ID: 15761378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.